Forest, Lundbeck Lose Bid To Limit Lexapro Claims
A federal judge has rejected the latest bid from H. Lundbeck A/S and its partner Forest Laboratories Inc. to pare down a patent dispute related to the antidepressant citalopram, ruling that...To view the full article, register now.
Already a subscriber? Click here to view full article